Zurueck zur Suche

Reporte zur Charge U029033

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

30Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 5 MI 3 FL 3 AZ 3 GA 2 NC 2 AR 2 PR 2 KY 1 CA 1 VA 1 SC 1

VAERS 2652817

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

schwer
Staat
KY
Alter
14,0
Geschlecht
F
Eingang
05.07.2023
Impfdatum
05.07.2023
Beginn
05.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Hyperhidrosis Loss of consciousness Muscle tightness Nervousness Tremor

Symptomtext

Pt appeared nervous during vaccination, but appeared to tolerate well for about a minute or two. Pt advised to remain seated. Pt lost consciousness, tensed her muscles and began to shake. This lasted about 10 seconds. Her mother and myself touched and aroused pt. Advised pt to remain seated another 15 minutes. Pt reported feeling dizzy and sweaty. Pt remained alert and oriented and was able to walk out of office after resting 15 minutes. Pt sat in waiting room during check out. She reported feeling okay and was able to walk out with her mom.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none reported
Vorgeschichte
asthma
Andere Medikamente
none reported
Allergien
Robaxin- rash
Vorherige Impfungen
-

VAERS 2580400

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

schwer
Staat
TX
Alter
14,0
Geschlecht
M
Eingang
13.02.2023
Impfdatum
13.02.2023
Beginn
13.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Nausea Presyncope Skin warm Vomiting

Symptomtext

The patient had a near syncopal episode after receiving the HPV vaccine where he slumped in the chair. It was the third injection out of three vaccines he received. the other two were HAVRIX and VARIVAX. His mother and I were able to catch him and hold him upright in the chair. He came around after jerking himself back to consciousness. I gave him a sucker and water and place a wrapped iced pack at the nape of his neck. His skin was sweaty and warm during the episode. I called someone to the room to translate to the mother and the patient the pathophysiology behind the reaction and that it is common with this vaccine. The mother was given the brochure to report the episode. She was told that I would be reporting the episode, however. The patient became nauseated and vomited x 2 during the explanation of the event to the Mom. After sitting and drinking water he recovered after approximately 10 minutes. He refused crackers after sitting for 5 more minutes and the nausea passed. He was fully alert and oriented upon recovery. He was able to ambulate to the waiting area without assistance where he waited an additional 10 minutes. The patient left without further incident or complaint. He had a steady gait upon discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2565712

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

schwer
Staat
GA
Alter
11,0
Geschlecht
F
Eingang
23.01.2023
Impfdatum
23.01.2023
Beginn
23.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness

Symptomtext

5 MIN AFTER VACCINES WAS ADMINISTERED, PT PASSED OUT. AFTER ABOUT 30 SECONDS AFTER USING AMONIA UNDER NOSE. PT CAME ABOUT. PT WAS GIVEN 12OZ DR PEPPER. VS 90/60 L ARM PULSE 71 AND O2 SAT 98%. pT SAT UP FOR ABOUT 15 MIN BEFORE LEAVING CLINIC. PT HAD NOT EATEN BEFORE GETTING VACCINES. pT WAS ESCORTED TO CAR BY MYSELF AND MOTHER. WAS GOING TO GET SOMETHING TO EAT.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Amoxil
Vorherige Impfungen
-

VAERS 2504532

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

schwer
Staat
NC
Alter
17,0
Geschlecht
F
Eingang
10.11.2022
Impfdatum
10.11.2022
Beginn
10.11.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Syncope less than 1 minute while sitting 2-3 minutes following administration of final vaccine-HPV. Patient aroused immediately afterwards after touching shoulder and calling her name. Provided oral hydration of water and monitored for an additional 15minutes. Following monitoring, escorted out of clinic accompanied by her family.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
None reported
Allergien
NKA
Vorherige Impfungen
-

VAERS 2471984

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

schwer
Staat
TX
Alter
17,0
Geschlecht
F
Eingang
07.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Nausea Pallor Seizure Syncope Vomiting

Symptomtext

Pt arrived to the country approximately 7 days ago. As per mom patient has no immunization record. Adm. Hep B, IPV, Var, and Tdap to left arm, with no adverse reaction. Administered MCV4 to right deltoid, pt had an episode to syncope followed by a seizure that lasted one minute. Pt awake, alert and oriented X3. States she felt nausea and vomited. Pt was pale and diaphoretic. 11:30, laid pt down and elevated lower extremities. Pt's face and lip color returned to her normal. States she feels fine and requested to sit up. Mother requested for the last two vaccines to be administered. Mom states pt always faints with vaccines and the sight of blood. Administered MMR and HPV to right arm with no adverse reaction. Pt states she felt fine. Instructed mom to go to the ER in case of emergency. Mother verbalized understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2464437

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

moderat
Staat
GA
Alter
18,0
Geschlecht
F
Eingang
29.09.2022
Impfdatum
01.09.2022
Beginn
03.09.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Hypoaesthesia Injected limb mobility decreased Injection site pain Musculoskeletal pain Pain Pain in extremity Paraesthesia Peripheral swelling

Symptomtext

Redness, swelling , soreness and numbness tingling to fingers on left hand. Redness and soreness spread from upper left arm (site of injection) to left shoulder blade. Difficult to move are very sore. Lasted 4 to 5 days. Took "Benadryl" four tablets "two in the morning and two in the evening". "Helped a lot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
denies
Vorgeschichte
denies
Andere Medikamente
denies
Allergien
denies
Vorherige Impfungen
-

VAERS 2657081

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

mild
Staat
MI
Alter
11,0
Geschlecht
M
Eingang
17.07.2023
Impfdatum
19.09.2022
Beginn
19.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pruritus Injection site swelling Injection site urticaria

Symptomtext

Pt was administered HPV9 vaccine in office. Pt noticed he had redness and hives around injection area around 7pm that night. Area was itchy/raised and responded well to Benadryl.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Focalin XR, Risperdal, Tylenol (PRN)
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2656517

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

mild
Staat
FL
Alter
12,0
Geschlecht
M
Eingang
14.07.2023
Impfdatum
14.07.2023
Beginn
14.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Vomiting

Symptomtext

At 10:30am on 7/14/2023The nurse administered TDaP (Adacel) into right deltoid and then HPV (Gardasil 9) IM into Left Deltoid. Immediately after administration, patient started to vomit The. Nurse Practitioner and Doctor were notified and patient was evaluated by the providers. Patient blood pressure was checked and patient was given water and instructed to lie down on table. Patient stayed in office for extra 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No know food or drug allergies
Vorherige Impfungen
-

VAERS 2520144

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

mild
Staat
AR
Alter
12,0
Geschlecht
F
Eingang
30.11.2022
Impfdatum
22.11.2022
Beginn
22.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Dizziness Flushing Injection site rash

Symptomtext

flush, faintness, weakness, dizziness, large rash at injection site x 4 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2433784

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

mild
Staat
PR
Alter
11,0
Geschlecht
F
Eingang
08.09.2022
Impfdatum
25.08.2022
Beginn
25.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dizziness Nausea

Symptomtext

After being vaccinated, the patient presents dizziness and nausea. She is given the required medical attention and remains under observation until she is stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2433746

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

mild
Staat
PR
Alter
11,0
Geschlecht
F
Eingang
08.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Nausea

Symptomtext

After being vaccinated, the patient presents dizziness and nausea. She is given the required medical attention and remains under observation until she is stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2366192

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

mild
Staat
CA
Alter
26,0
Geschlecht
M
Eingang
12.07.2022
Impfdatum
11.07.2022
Beginn
11.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Urticaria

Symptomtext

Patient developed urticaria on neck and bilateral upper extremities about 6 hours after HPV vaccine was given. Hives improved by the following morning but still some mild itching. Advised patient to start benadryl.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
Food allergy, dog allergy, environmental allergies
Andere Medikamente
finasteride 1 mg, levocetirizine 5 mg, azelastine nasal spray PRN, fluticasone nasal spray PRN
Allergien
peanuts, tree nuts, dogs, grass, pollen
Vorherige Impfungen
-

VAERS 2685098

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u029033

gering
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
22.09.2023
Impfdatum
05.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Nurse administered meningococcal B vaccine instead of meningococcal conjugate. No adverse reaction reported by parent or patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
NO
Allergien
NO
Vorherige Impfungen
-

VAERS 2653906

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u029033

gering
Staat
VA
Alter
-
Geschlecht
M
Eingang
10.07.2023
Impfdatum
01.06.2023
Beginn
12.06.2023
Tage bis Beginn
11,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product confusion Wrong product administered

Symptomtext

she inadvertently administered PREVNAR 20 instead of GARDASIL-9 due to product confusion; no adverse event; Nurse calling to report that she inadvertently administered PREVNAR 20 instead of GARDASIL-9; This spontaneous report was received from Other Health Professional (nurse) and refers to an unknown age male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 12-JUN-2023, the nurse inadvertently administered pneumococcal vaccine conj 20v (crm197) (PREVNAR 20) (strength, formulation, lot #, expiry date, route of administration, and indication were not provided) instead of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) to the patient (Wrong product administered) due to product confusion. The patient had already received his first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) previously and this was supposed to be his second dose. On an unspecified date in June 2023, the patient came back to the office and received his second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, lot #u029033, expiration date: 13-MAR-2024 (strength, route of administration, and indication were not provided). The patient has no symptoms (no adverse event). The causality between all the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645903

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
SC
Alter
11,0
Geschlecht
F
Eingang
15.06.2023
Impfdatum
22.05.2023
Beginn
22.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

No Adverse Reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2587432

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
27.02.2023
Impfdatum
10.02.2023
Beginn
10.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no adverse event; 2 Separate, Improperly Stored GARDASIL 9 Doses were administered to 2 Separate Patients on 02/10/2023. Improperly Stored / Administered Vaccine; This spontaneous report has been received from a consumer, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 10-FEB-2023, the patient was vaccinated with an improperly storage dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection as prophylaxis (lot number: U029033, which was determined to be valid, with an expiration date on 13-MAR-2024) (product storage error) (strength, dose, scheme, route and anatomical location of administration were not reported). The administered dose underwent a temperature excursion of 30.9 degrees Fahrenheit (F) for 4 hours and 30 minutes. No previous temperature excursion occurred, and no additional adverse event was reported. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2302USA005112: US-009507513-2302USA007648: US-009507513-2302USA005112:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2555029

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
AZ
Alter
0,2
Geschlecht
F
Eingang
10.01.2023
Impfdatum
05.01.2023
Beginn
05.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE reported; GARDASIL 9 was administered to a 2-month old patient today 1/5/2023; This spontaneous report was received from a nurse referring to a 2-month-old female patient. The patient's medical history, historical drugs, concurrent conditions, and concomitant drugs were not reported. On 05-JAN-2023 (also reported as "today"), the patient was administered HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (lot#: U029033, expiration date: 13-MAR-2024; strength, dose, route of administration, and anatomical location were not reported) for prophylaxis (product administered to patient of inappropriate age). No additional adverse event details available. No additional adverse events reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2539390

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u029033

gering
Staat
FL
Alter
46,0
Geschlecht
M
Eingang
21.12.2022
Impfdatum
18.12.2022
Beginn
18.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient received 2nd dose of Gardasil 9 after turning 46 years old. Patient turned 46 years old 3 days before getting the shot. Patient is okay with getting the 2nd dose but it was not appropriate due to age. Patient did not experience any side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2538534

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
UT
Alter
12,0
Geschlecht
U
Eingang
21.12.2022
Impfdatum
06.12.2022
Beginn
05.04.2022
Tage bis Beginn
-
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Inappropriate schedule of product administration

Symptomtext

Medical assistant calling to report that a patient was inadvertently administered a 4th dose of GARDASIL9 on 06-DEC-2022; the second dose was given two years later; This spontaneous report was received from other health professional (medical assistant) and refers to a 14-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date in 2020, at the age of 12, the patient was vaccinated with the first dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) administered for prophylaxis (dose, frequency, lot #, expiration date, and route of administration were not provided). There was an interruption in the dosing schedule between dose one and dose two and the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, frequency, lot #, expiration date, and route of administration were not provided) was given two years later on 05-APR-2022 for prophylaxis (inappropriate schedule of product administration). The third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, frequency, lot #, expiration date, and route of administration were not provided) was administered on 01-NOV-2022 for prophylaxis. On 06-DEC-2022, the patient was inadvertently administered a 4th dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (Extra dose administered), 0.5 ml, lot # U029033 (lot number was verified to be valid lot number) expiration date 13-MAR-2024, (route of administration was not provided) for prophylaxis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485483

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
AZ
Alter
15,0
Geschlecht
M
Eingang
21.10.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient got an extra dose of tdap and MCV 4 outside of recommended schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2485471

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
AZ
Alter
-
Geschlecht
M
Eingang
21.10.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient got an extra dose of tdap outside of recommended schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2461563

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u029033

gering
Staat
TX
Alter
14,0
Geschlecht
U
Eingang
27.09.2022
Impfdatum
09.09.2022
Beginn
09.09.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

No other AEs; GARDASIL 9 was inadvertenly administered to a 14 year old who had already completed a 2 dose series. Caller states the patient was ordered a Flu vaccine but she administered a GARDASIL 9 because that is what she usually administered; but she administered a GARDASIL 9 because that is what she usually administered; This spontaneous report was received from a medical assistant referring to a 14 year old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. The patient was ordered a flu vaccine (indication, dose, route of administration, vaccination scheme frequency, anatomical location, lot number and expiration date were not reported). However, on 09-SEP-2022, instead of the flu vaccine, the patient was inadvertently vaccinated with the third dose (as the patient already completed a 2 dose series) of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) syringe injection (lot # u029033, expiration date:13-MAR-2024) at a dose of 0.5 milliliter, intramuscular as prophylaxis (anatomical location not reported) (wrong product administered), because that is what the reporter usually administered (product confusion). No other adverse events (AEs) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2454785

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u029033

gering
Staat
OH
Alter
12,0
Geschlecht
F
Eingang
22.09.2022
Impfdatum
21.09.2022
Beginn
01.09.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

patient was given an IM inject when the vaccination was to be given as subcutaneous injection, patient has not had any adverse symptoms as of this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2452934

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
TX
Alter
14,0
Geschlecht
U
Eingang
21.09.2022
Impfdatum
09.09.2022
Beginn
09.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

No other AEs or PQC reported; Caller reports GARDASIL 9 was inadvertently administered to a 14 year old who had already completed a 2 dose series. Caller states the patient was ordered a "Flu Vaccine" but she administered a GARDASIL 9 because that is what she "Usually administer; This spontaneous report was received from a medical assistant referring to a 14-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not provided. On 09-SEP-2022, the patient was inadvertently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) syringe injection, at dose 0.5 milliliter (lot number U029033 was verified to be a valid number, with an expiration date reported and established as 13-MAR-2024), administered intramuscularly for prophylaxis (strength was not provided), instead of flu vaccine (manufacturer unknown) (wrong product administered). The patient had already completed 2 doses series of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No additional adverse events were reported. It was reported that the patient ordered a flu vaccine (manufacturer unknown), but received hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) because that is what the facilitator "usually administered".

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2426455

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
AR
Alter
7,0
Geschlecht
F
Eingang
01.09.2022
Impfdatum
30.08.2022
Beginn
30.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Client or client parents did not report any adverse events, treatments or signs or symptoms upon return to clinic the following day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported by client or parents.
Vorgeschichte
None reported by client or parents.
Andere Medikamente
None reported by client or parents.
Allergien
None reported by client or parents.
Vorherige Impfungen
-

VAERS 2426129

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
FL
Alter
0,8
Geschlecht
U
Eingang
01.09.2022
Impfdatum
25.08.2022
Beginn
25.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No adverse event; she mentioned that a 9 month old was administered GARDASIL 9 on 25Aug2022; This spontaneous report was received from a physician and refers to a 9-month-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 25-AUG-2022, the patient was vaccinated with a dose of 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) pre-filled syringe, lot #U029033, expiration date: 13-MAR-2024 (dosage regimen, anatomical location, and route of administration were not provided) as prophylaxis (Inappropriate age at vaccine administration). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2425208

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
OK
Alter
16,0
Geschlecht
F
Eingang
31.08.2022
Impfdatum
31.08.2022
Beginn
31.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

GAVE THIRD HPV THAT WAS NOT NEEDED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2419271

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
MI
Alter
17,0
Geschlecht
F
Eingang
24.08.2022
Impfdatum
23.08.2022
Beginn
23.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

I gave the HPV vaccine instead of Trumenba vaccine. No symptoms or adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
ANEMIA- HEMOGLOBIN 11.7
Vorgeschichte
ASTHMA
Andere Medikamente
Multi vitamin, Loratadine
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2398139

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
MI
Alter
11,0
Geschlecht
F
Eingang
01.08.2022
Impfdatum
29.07.2022
Beginn
29.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Patient received Meningococcal B (Bexsero) instead of Meningococcal (Menactra). Patient had no reaction to vaccination while in clinic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No known illnesses.
Vorgeschichte
No known chronic or long-standing conditions.
Andere Medikamente
No medications.
Allergien
NKA
Vorherige Impfungen
-

VAERS 2338889

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U029033

gering
Staat
NC
Alter
16,0
Geschlecht
F
Eingang
28.06.2022
Impfdatum
28.06.2022
Beginn
28.06.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

Patient was given HPV dose three instead of Men B vaccine. Patient already completed HPV series.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
Bilateral myopia Scoliosis
Andere Medikamente
Claritin
Allergien
NKA
Vorherige Impfungen
-